Effectiveness of very low doses of immunotherapy in advanced renal cell cancer.

Tekijä Buzio, C., De Palma, G., Passalacqua, R., Potenzoni, D., Ferrozzi, F., Cattabiani, M. A., Manenti, L., Borghetti, A.
Julkaistu 1997

Antiangiogenic activity of aplidine, a new agent of marine origin

Tekijä Taraboletti, G, Poli, M, Dossi, R, Manenti, L, Borsotti, P, Faircloth, G T, Broggini, M, D'Incalci, M, Ribatti, D, Giavazzi, R
Julkaistu 2004

An exploratory, open-label, randomized, multicenter study to investigate the pharmacodynamics of a glycoengineered antibody (imgatuzumab) and cetuximab in patients with operable he...

Tekijä Temam, S, Spicer, J, Farzaneh, F, Soria, J C, Oppenheim, D, McGurk, M, Hollebecque, A, Sarini, J, Hussain, K, Soehrman Brossard, S, Manenti, L, Evers, S, Delmar, P, Di Scala, L, Mancao, C, Feuerhake, F, Andries, L, Ott, M G, Passioukov, A, Delord, J P
Julkaisussa Ann Oncol (2017)